E-nitiate Biopharmaceuticals Funding: $14M Raised, Series A

E-nitiate Biopharmaceuticals has raised $14M in total funding. Latest round: Series A. Backed by Time Investment, Taikun Fund, Linping State Investment.

E-nitiate Biopharmaceuticals funding overview

E-nitiate Biopharmaceuticals has raised $14M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series A announced in April 2023. The round record for E-nitiate Biopharmaceuticals runs through 2023; nothing later has been disclosed. Investors on record include Time Investment, Taikun Fund, Linping State Investment, Hangzhou Golden Investment Industry Fund. 4 distinct backers are named across the disclosed rounds.

E-nitiate Biopharmaceuticals at a glance

Total raised
$14M
Latest round
Series A
Latest round date
April 2023
Notable investors
Time Investment, Taikun Fund, Linping State Investment, Hangzhou Golden Investment Industry Fund

Frequently asked about E-nitiate Biopharmaceuticals funding

How much has E-nitiate Biopharmaceuticals raised?
E-nitiate Biopharmaceuticals has raised $14M in total disclosed funding across the rounds on record.
Who has invested in E-nitiate Biopharmaceuticals?
Time Investment, Taikun Fund, Linping State Investment, Hangzhou Golden Investment Industry Fund are named among the investors backing E-nitiate Biopharmaceuticals.
What was the latest E-nitiate Biopharmaceuticals funding round?
The most recent disclosed round is a Series A, announced in April 2023.
Where is E-nitiate Biopharmaceuticals based?
No headquarters location is disclosed for E-nitiate Biopharmaceuticals.
When did E-nitiate Biopharmaceuticals last raise?
The last disclosed E-nitiate Biopharmaceuticals round closed in April 2023 at Series A.

Every E-nitiate Biopharmaceuticals figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies at a similar stage.

Companies related to E-nitiate Biopharmaceuticals (30)

Browse related funding lists (3)

Company funding database · Investor directory · Founder database · Mega-rounds 2026

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades